ENDRA Life Sciences (NDRA) Liabilities and Shareholders Equity (2016 - 2021)
Historic Liabilities and Shareholders Equity for ENDRA Life Sciences (NDRA) over the last 6 years, with Q3 2021 value amounting to $15.3 million.
- ENDRA Life Sciences' Liabilities and Shareholders Equity rose 18564.96% to $15.3 million in Q3 2021 from the same period last year, while for Dec 2021 it was $51.5 million, marking a year-over-year increase of 14058.53%. This contributed to the annual value of $8.8 million for FY2020, which is 2213.83% up from last year.
- Per ENDRA Life Sciences' latest filing, its Liabilities and Shareholders Equity stood at $15.3 million for Q3 2021, which was up 18564.96% from $17.2 million recorded in Q2 2021.
- In the past 5 years, ENDRA Life Sciences' Liabilities and Shareholders Equity registered a high of $18.9 million during Q1 2021, and its lowest value of $545126.0 during Q1 2017.
- In the last 5 years, ENDRA Life Sciences' Liabilities and Shareholders Equity had a median value of $5.4 million in 2020 and averaged $6.8 million.
- Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first skyrocketed by 114779.72% in 2017, then crashed by 8272.78% in 2018.
- Quarter analysis of 5 years shows ENDRA Life Sciences' Liabilities and Shareholders Equity stood at $6.1 million in 2017, then increased by 17.95% to $7.2 million in 2018, then dropped by 0.64% to $7.2 million in 2019, then increased by 22.14% to $8.8 million in 2020, then soared by 74.72% to $15.3 million in 2021.
- Its Liabilities and Shareholders Equity was $15.3 million in Q3 2021, compared to $17.2 million in Q2 2021 and $18.9 million in Q1 2021.